- Papers in database
- 10
- Primary author
- 9 papers
- Years active
- 2015 – 2023
Papers (10)
- 2023Primary authorProbiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study10.1097/MD.0000000000033751
- 2023Primary authorThe effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study10.1097/MD.0000000000033109
- 2020Primary authorComparative evaluation for thermostability and gastrointestinal survival of probiotic Bacillus coagulans MTCC 5856.10.1093/bbb/zbaa116
- 2020Application of Bacillus coagulans in Animal Husbandry and Its Underlying Mechanisms10.3390/ani10030454
- 2019Primary authorEvaluation of probiotic Bacillus coagulans MTCC 5856 viability after tea and coffee brewing and its growth in GIT hostile environment.10.1016/J.FOODRES.2018.12.003
- 2018Primary authorGalactomannan from Trigonella foenum‐graecum L. seed: Prebiotic application and its fermentation by the probiotic Bacillus coagulans strain MTCC 585610.1002/fsn3.606
- 2018Primary authorRapid assessment of viable but non-culturable Bacillus coagulans MTCC 5856 in commercial formulations using Flow cytometry10.1371/journal.pone.0192836
- 2018Primary authorBacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study10.29219/fnr.v62.1218
- 2016Primary authorEvaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain10.1007/s11274-016-2027-2
- 2015Primary authorBacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study10.1186/s12937-016-0140-6